[Federal Register Volume 85, Number 158 (Friday, August 14, 2020)]
[Notices]
[Page 49665]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-17789]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Notice of Meeting
Pursuant to Public Law 92-463, notice is hereby given that the
Substance Abuse and Mental Health Services Administration's (SAMHSA)
Center for Substance Abuse Prevention's (CSAP) Drug Testing Advisory
Board (DTAB) will convene via web conference on September 1st, 2020,
from 10:00 a.m. EDT to 5:30 p.m. EDT.
The board will meet in open-session September 1st, 2020, from 10:00
a.m. EDT to 1:00 p.m. EDT to discuss the Mandatory Guidelines for
Federal Workplace Drug Testing Programs with updates from the
Department of Transportation and the Nuclear Regulatory Commission.
Other discussion topic include an update on marijuana studies and
efforts. The board will meet in closed-session on September 1st, 2020,
from 2:00 p.m. EDT to 5:30 p.m. EDT to discuss confidential issues
surrounding the proposed Mandatory Guidelines for Federal Workplace
Drug Testing Programs (hair), preliminary and unpublished studies from
the Johns Hopkins University Behavioral Pharmacology Research Unit
(BPRU), additional drugs (fentanyl and methadone) that may be tested
for in the future, and lastly, emerging issues on marijuana. Therefore,
the portion of the meeting on September 1st, 2020, from 2:00 p.m. EDT
to 5:30 p.m. EDT, is closed to the public, as determined by the
Assistant Secretary for Mental Health and Substance Use, SAMHSA, in
accordance with 5 U.S.C. 552b(c)(4) and (9)(B), and 5 U.S.C. App. 2,
Section 10(d).
Meeting registration information can be completed at http://snacregister.samhsa.gov/MeetingList.aspx. Web conference and call
information will be sent after completing registration. Meeting
information and a roster of DTAB members may be obtained by accessing
the SAMHSA Advisory Committees website, https://www.samhsa.gov/about-us/advisory-councils/meetings or by contacting the Designated Federal
Officer, Jennifer Fan.
Committee Name: Substance Abuse and Mental Health Services
Administration, Center for Substance Abuse Prevention, Drug Testing
Advisory Board.
Dates/Time/Type: September 1, 2020, from 10:00 a.m. to 1:00 p.m.
EDT: OPEN. September 1, 2020, from 2:00 p.m. to 5:30 p.m. EDT: CLOSED.
Place: Substance Abuse and Mental Health Services Administration,
5600 Fishers Lane, Rockville, MD 20857.
Contact: Jennifer Fan, Senior Pharmacist, Center for Substance
Abuse Prevention, 5600 Fishers Lane, Room 16N06D, Rockville, Maryland
20857, Telephone: (240) 276-1759, Email: [email protected].
Anastasia Marie Donovan,
Policy Analyst.
[FR Doc. 2020-17789 Filed 8-13-20; 8:45 am]
BILLING CODE 4162-20-P